Home
Creatd Inc
Correction: Jeremy Frommer Resigns as Enzolytics, Inc.'s CEO and Board Member
Business
Jun 1 2025
4 min read

Correction: Jeremy Frommer Resigns as Enzolytics, Inc.'s CEO and Board Member

Creatd, Inc. (OTC: CRTD) confirms that Jeremy Frommer has officially resigned from his position as Chief Executive Officer and as a member of the Board of Directors of Enzolytics, Inc. (OTC: ENZC) , effective immediately.

Mr. Frommer assumed leadership of ENZC during a period of significant instability. In his tenure, he executed a broad restructuring that included the termination of the prior executive team, resolution of longstanding shareholder conflicts, elimination of outstanding debt and liabilities, and the dismissal of multiple nuisance lawsuits. These efforts cleared the way for a comprehensive rebuild of the company’s foundation.

Mr. Frommer extends his best wishes to the board and leadership team of ENZC in their continued efforts to revitalize the business and unlock long-term shareholder value. 

About Enzolytics: 
Enzolytics, Inc. (OTC: ENZC) is a biotechnology company focused on the research, development, and commercialization of therapeutics for infectious diseases. Its innovative products include patented therapies aimed at treating HIV, AIDS, cancer, and other conditions.

About Creatd: 
Creatd, Inc. focuses on investments and operations across technology, media, aviation, advertising, and consumer sectors. By leveraging its expertise in structured finance and acquisitions, Creatd identifies and nurtures opportunities within small-cap companies, driving growth and innovation across its diverse portfolio.


Forward Looking Statements: 
Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “intends,” “plans,” “believes” and “projects”) may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings.
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern